{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:00:56Z","timestamp":1791216056573,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:00:00Z","timestamp":1548201600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Ultrasound"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12947-019-0151-5","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T11:24:23Z","timestamp":1548242663000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Role of cardiac imaging in Anderson-Fabry cardiomyopathy"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3530-1239","authenticated-orcid":false,"given":"Walter","family":"Serra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Marziliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,23]]},"reference":[{"key":"151_CR1","doi-asserted-by":"publisher","unstructured":"2014 ESC Practice Guidelines on diagnosis and management of hypertrophic cardiomyopathy Eur Heart Journal (2014) 35:2733\u20132779 - \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehu284\n                    \n                   .","DOI":"10.1093\/eurheartj\/ehu284"},{"key":"151_CR2","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.jacc.2005.11.070","volume":"47","author":"M Pieroni","year":"2006","unstructured":"Pieroni M, Chimenti C, De Cobelli F, et al. Fabry's disease cardiomyopathy:echocardiographic detection of endomyocardial glycosphingolipid compartmentalization. J Am Coll Cardiol. 2006;47:1663\u201371.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"151_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ultrasmedbio.2010.10.017","volume":"37","author":"N M","year":"2011","unstructured":"M N, Liu D, Hu K, Herrmann S, Breunig F, Strotmann J, St\u00f6rk S, Voelker W, Ertl G, Wanner C, Weidemann F. Prominent papillary muscles in Fabry disease: a diagnostic marker? Ultrasound Med Biol. 2011 jan;37(1):37\u201343. \n                    https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2010.10.017\n                    \n                  .","journal-title":"Ultrasound Med Biol"},{"key":"151_CR4","doi-asserted-by":"publisher","unstructured":"Serra W, Fagnani S, Ardissino D, Gherli T. Late-onset cardiac variant of Fabry disease responsive to short-term treatment with Agalsidase alpha. J Clinic Experiment Cardiol. 2010;1:109. \n                    https:\/\/doi.org\/10.4172\/2155-9880.1000109\n                    \n                  .","DOI":"10.4172\/2155-9880.1000109"},{"issue":"5","key":"151_CR5","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10897-013-9613-3","volume":"22","author":"DA Laney","year":"2013","unstructured":"Laney DA, et al. Fabry disease practice guidelines: recommendations of the National Society of genetic counselors. J Genet Couns. 2013;22(5):555\u201364.","journal-title":"J Genet Couns"},{"issue":"9","key":"151_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/01.gim.0000237866.70357.c6","volume":"8","author":"CM Eng","year":"2006","unstructured":"Eng CM, et al. Fabry disease: guidelines for the evaluation and management of multi-organ system involvement. Genet Med. 2006;8(9):539\u201348.","journal-title":"Genet Med"},{"issue":"11","key":"151_CR7","first-page":"630","volume":"16","author":"F Pieruzzi","year":"2015","unstructured":"Pieruzzi F, et al. Heart involvement in Anderson-Fabry disease: Italian recommendations for diagnostic, follow up and therapeutic management. G Ital Cardiol (Rome). 2015;16(11):630\u20138.","journal-title":"G Ital Cardiol (Rome)"},{"key":"151_CR8","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1161\/CIRCULATIONAHA.109.849828","volume":"120","author":"CA Gange","year":"2009","unstructured":"Gange CA, Link MS, Maron MS. Utility of Cardiovascular Magnetic Resonance in the Diagnosis of Anderson-Fabry Disease. Circulation. 2009;120:e96\u20137.","journal-title":"Circulation"},{"key":"151_CR9","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","volume":"34","author":"A Mehta","year":"2004","unstructured":"Mehta A, Ricci R, Widmer U, et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry outcome survey. Eur J Clin Investig. 2004;34:236\u201342.","journal-title":"Eur J Clin Investig"},{"key":"151_CR10","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/ejechocard\/jer109","volume":"12","author":"J Zamorano","year":"2011","unstructured":"Zamorano J, Serra V, Perez de Isla L, et al. Usefulness of tissue Doppler on early detection of cardiac disease in Fabry patients and potential role of enzyme replacement therapy (ERT) for avoiding progression of disease. Eur J Echocardiogr. 2011;12:671\u20137.","journal-title":"Eur J Echocardiogr"},{"key":"151_CR11","unstructured":"F. Weidemann a, A. Linhart b, L. Monserrat c, J. Strotmann . Cardiac challenges in patients with Fabry disease. IJC (2009), doi:10.1016\/j.ijcard.2009.08.00."},{"key":"151_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.amjcard.20","volume":"103","author":"JP Sun","year":"2009","unstructured":"Sun JP, Stewart WJ, Yang XS, Donnell RO, Leon AR, Felner JM, Thomas JD, Merlino JD. Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography. Am J Cardiol. 2009;103:411\u20135. \n                    https:\/\/doi.org\/10.1016\/j.amjcard.20\n                    \n                  .","journal-title":"Am J Cardiol"},{"key":"151_CR13","doi-asserted-by":"publisher","unstructured":"Shanks M MD ThompsonIan RB . Paterson ID, Oudit GY. MD, PhD Systolic and diastolic function assessment in Fabry disease patients using speckle-tracking imaging and comparison with conventional echocardiographic measurements. J Am Soc Echocardiogr 2013;26(12):1407\u20131414. doi: \n                    https:\/\/doi.org\/10.1016\/j.echo.2013.09.005\n                    \n                  .","DOI":"10.1016\/j.echo.2013.09.005"},{"key":"151_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/08035320510028049","volume":"94","author":"C Kampmann","year":"2005","unstructured":"Kampmann C, Baehner FA, Whybra C, et al. The right ventricle in Fabry disease. Acta Paediatr Suppl. 2005;94:15\u20138 discussion 9\u20130.","journal-title":"Acta Paediatr Suppl"},{"issue":"3","key":"151_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.15420\/aer.2016:13:3","volume":"5","author":"EJ Rowin","year":"2016","unstructured":"Rowin EJ, Maron MS. The role of cardiac MRI in the diagnosis and risk stratification of hypertrophic cardiomyopathy. Arrhythm Electrophysiol Rev. 2016;5(3):197\u2013202. \n                    https:\/\/doi.org\/10.15420\/aer.2016:13:3\n                    \n                  .","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"151_CR16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","volume":"111","author":"AM Maceira","year":"2005","unstructured":"Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005;111:186\u201393. \n                    https:\/\/doi.org\/10.1161\/01.CIR.0000152819.97857.9D\n                    \n                  .","journal-title":"Circulation"},{"key":"151_CR17","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/j.ehj.2003.09.017","volume":"24","author":"JC Moon","year":"2003","unstructured":"Moon JC, Sachdev B, Elkington AG, et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J. 2003;24:2151\u20135.","journal-title":"Eur Heart J"},{"issue":"Suppl1","key":"151_CR18","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/1532-429X-13-S1-P276","volume":"13","author":"EB Tham","year":"2011","unstructured":"Tham EB, Chow K, Spavor M, Pagano JJ, Haykowsky M, Thompson RB. Degree ofdiffuse fibrosis measured by mri correlates with lv remodelling in childhood cancer survivors after anthracycline chemotherapy. J Cardiovasc Mag Reson. 2011;13(Suppl1):276.","journal-title":"J Cardiovasc Mag Reson"},{"key":"151_CR19","doi-asserted-by":"crossref","unstructured":"T1 mapping in Cardiac MRI D.Radencovich,S Weingarthner,G Captur Heart Fail Review 2017, 22:415\u2013430.","DOI":"10.1007\/s10741-017-9627-2"},{"key":"151_CR20","doi-asserted-by":"publisher","unstructured":"Sabrina Nordin, Rebecca Kozor, Heerajnarain Bulluck, Silvia Castelletti, Stefania Rosmini, Amna et al .Cardiac Fabry disease with late gadolinium enhancement is a chronic inflammatory cardiomyopathy. JACC \n                    Volume 68, Issue 15, October 2016\n                    \n                   DOI: \n                    https:\/\/doi.org\/10.1016\/j.jacc.2016.07.741\n                    \n                  .","DOI":"10.1016\/j.jacc.2016.07.741"}],"container-title":["Cardiovascular Ultrasound"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12947-019-0151-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12947-019-0151-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12947-019-0151-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T19:10:23Z","timestamp":1579720223000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiovascularultrasound.biomedcentral.com\/articles\/10.1186\/s12947-019-0151-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,23]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["151"],"URL":"https:\/\/doi.org\/10.1186\/s12947-019-0151-5","relation":{},"ISSN":["1476-7120"],"issn-type":[{"value":"1476-7120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,23]]},"assertion":[{"value":"15 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"Not available.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1"}}